MF
FLGT icon

Magnetar Financial’s Fulgent Genetics FLGT Stock Holding History

Magnetar Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,206
Closed -$321K – 1236
2025
Q4 		$321K Buy
+12,206
New +$317K ﹤0.01% 667
2025
Q3 		– Sell
-15,101
Closed -$300K – 996
2025
Q2 		$300K Buy
+15,101
New +$294K ﹤0.01% 702
2025
Q1 		– Sell
-16,977
Closed -$314K – 805
2024
Q4 		$314K Buy
+16,977
New +$331K 0.01% 462
2024
Q3 		– Sell
-13,088
Closed -$257K – 584
2024
Q2 		$257K Buy
+13,088
New +$273K 0.01% 411
2021
Q3 		– Sell
-3,415
Closed -$315K – 1375
2021
Q2 		$315K Sell
3,415
-642
-16% -$51.3K ﹤0.01% 1019
2021
Q1 		$392K Buy
+4,057
New +$419K ﹤0.01% 874

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Magnetar Financial's FLGT Position: Q1 2026 in Review

Magnetar Financial sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 12,206 shares — an estimated $321K sold.

Magnetar Financial first reported a position in FLGT in Q1 2021 and held it in 6 quarters. The position peaked at $392K in Q1 2021. 158 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Magnetar Financial reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Magnetar Financial sold 12,206 Fulgent Genetics shares in Q1 2026, an estimated $321K.
  • Magnetar Financial first reported a position in Fulgent Genetics in Q1 2021 and held it in 6 quarters.
  • Magnetar Financial's Fulgent Genetics position peaked at $392K in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.